Newborn sickle cell disease screening: the Jamaican experience (1995-2006)

Area of Science:

• Public Health
• Genetics
• Pediatrics

Background:

• Sickle cell disease (SCD) is a significant global health concern, particularly in regions with high carrier frequencies.
• Newborn screening programs are essential for early detection and management of genetic blood disorders.
• Jamaica has an established newborn screening program for sickle haemoglobinopathies.

Purpose of the Study:

• To evaluate the effectiveness of the existing newborn sickle haemoglobinopathy screening program in Jamaica.
• To assess survival rates and clinical outcomes in infants diagnosed with sickle cell disease (Hb SS) through the screening program.

Main Methods:

• Retrospective analysis of infants screened for sickle cell disease (Hb SS) between November 1995 and July 2006.
• Comparison of clinical events and mortality rates with historical data from the Jamaican Sickle Cell Cohort Study.
• Focus on patients with homozygous sickle cell disease (Hb SS).

Main Results:

• The study included 435 patients with Hb SS disease.
• Acute chest syndrome was the most frequent clinical event (approx. 50%).
• Mortality was significantly lower (1.8%) compared to the Jamaican Sickle Cell Cohort Study (17.6%), with reduced hospital admissions and serious illness episodes.

Conclusions:

• Newborn screening for sickle cell disease (SCD) in Jamaica demonstrates improved survival outcomes.
• The findings support the benefits of early detection and intervention for SCD.
• Emphasizes the need for comprehensive care systems within newborn screening programs for maximal effectiveness.